Trump's liability-first AI policy will force UK regulated firms to choose AI partners more carefully. We believe that's overdue—and it will separate tools built for accountability from tools built for speed.
AI Governance  Trovix BriefLegal · Financial Services · Insurance · Accountancy

The Trump administration's decision to enforce AI safety through existing liability law rather than new regulation has immediate consequences for mid-market UK firms. When an AI model fails—whether it misclassifies risk, generates wrong legal analysis, or provides faulty financial advice—someone now has to pay. The question of who that someone is will migrate from Washington into UK courtrooms, boardrooms and FCA inquiries. For legal practices, insurers, financial advisers and accountancies, this means the AI tools you adopt today could become litigation exhibits tomorrow. A chatbot that seems cost-effective but lacks transparent audit trails, training data provenance, or human sign-off workflows becomes a liability vector the moment it produces a wrong answer in a regulated context. This is not hypothetical: it is how US tort law works, and the UK's regulators—particularly the SRA, FCA and ICO—are already aligned with this thinking.

What this story actually reveals is that the AI industry has been selling convenience without accountability. Products marketed as autonomous decision-makers—whether they are general-purpose large language models like ChatGPT or specialized tools like some versions of Harvey or Luminance—have always ducked the hard question: who is responsible when the model hallucinates, misreads a contract clause, or applies outdated case law? The US liability approach forces that question into the open. It says: use the AI, but own the output. That is a different operating model from the one most generalist AI vendors have built. It requires logging, version control, human review checkpoints, and clear audit chains—precisely the governance overhead that many firms have skipped because their chosen tools do not enforce it. The pattern is clear: regulation is moving from 'how should AI work?' to 'who pays when it fails?' and the answer is: you do, unless you can prove you acted reasonably.

Trovix's approach has always been built around that accountability requirement. We do not position AI as a replacement for judgment; we position it as a decision support tool that leaves a verifiable trace. When Trovix Brief ingests a contract or intake form, the model's decisions are logged, the source data is preserved, and the hand-off to a human reviewer is explicit and documented. When a partner at your firm signs off on an AI-assisted outcome, they can point to exactly what the model saw, what it recommended, and why a human chose to accept, modify or reject that recommendation. That audit trail is not optional compliance theatre—it is your defence in the liability scenario the Trump administration is now making inevitable. Compare this to tools that operate as black boxes, where the AI vendor shrugs and says 'the model decided' but cannot show you the reasoning. That approach will not survive first contact with a negligence claim or an FCA enforcement action.

The practical step for your firm this quarter is to audit the AI tools you are already using against a simple test: could your regulator (SRA, FCA, PRA, or ICO) trace the decisions this tool makes, and would you win a negligence case if it got something wrong? If the answer to either question is 'we don't know' or 'probably not', you have a governance gap. You need tools that produce audit logs, not just outputs. You need clarity on training data provenance, not just vendor assurances. Most importantly, you need to map where human review and sign-off are mandatory—not just recommended—and ensure your AI stack enforces that. Trovix Audit exists to help you do that mapping and to close the gaps you find. If you are six months into a Copilot pilot with no formal governance layer, that is the fire you should be putting out now, before a bad outcome turns into a case study.

Source: Bloomberg News

Related Trovix product:

Trovix Brief →Book a demo →